NRIX vs TECH
Nurix Therapeutics Inc (NRIX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NRIX revenue for 2024-11-30 was $54.5M. Net income was -$193.6M. Revenue was down 29.1% from 2023-11-30 to 2024-11-30. NRIX currently screens at market cap $1.77B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NRIX currently screens at market cap $1.77B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NRIX and TECH stock pages for the full models.
Not investment advice.